NCT02299297View on ClinicalTrials.gov

Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Alopecia Areata
Interventions
DRUG

Tofacitinib

Dosage/Frequency: 5mg - 10mg, oral, twice daily

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

Locks of Love

OTHER

lead

Columbia University

OTHER

NCT02299297 - Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis | Biotech Hunter | Biotech Hunter